Posted by Michael Wonder on 16 Jun 2017
New type of treatment for Crohn’s disease is approved by NICE
16 June 2017 - Following NICE recommendations, patients with Crohn’s disease will have routine NHS access to drug ustekinumab, which offers a new way of treating the condition.
Ustekinumab (also called Stelara, manufactured by Janssen) will be available for patients with moderate to severe Crohn’s disease.
It is recommended by NICE as an option for treating the disease in adults who have had little or no response, or an intolerance to existing therapies.
